-
First California Vioxx Trial Started On June 21: Grossberg v. Merck
Trial Consists Of Only Single Case, Not The Four-Case Group Judge Chaney Had Scheduled A June 21, 2006 article in the San Jose Mercury News reported that the first Vioxx trial in California started…
-
Cox-2 Drugs Increase Risk Of Second Heart Attack Or Death When Used After First Heart Attack
Will June 2006 Circulation Article Affect Lawsuits Involving Bextra, Celebrex, And Vioxx? In mid-June 2006 the medical journal Circulation published online an early-release version of a study which reveals that Bextra, Celebrex, and Vioxx…
-
Beware Of Deception By Drug Companies: Former NEJM Editor In Chief
Prescription Drug Companies Have Used Deceptive Practices: NJ Public Interest Research Group Going back in time a bit, the March 1, 2005 edition of Bottom Line/Health featured an excellent article for patients and doctors,…
-
Ketek: Side-Effects May Outweigh Its Benefits
And Sanofi-Aventis Suspends Enrollment In A Pediatric Clinical Trial In May and June 2006 there was a continuing debate on several levels about whether or not Ketek (telithromycin) should be withdrawn from the market…
-
Should The Popular Asthma Drug Advair Be Pulled From The Market?
Study Finds Increased Risk Of Serious Side Effects For A Broad Range Of Users A study published in June 2006 by a leading medical journal concludes that GlaxoSmithKline’s popular asthma drug Advair is perhaps…
-
Natrecor: A Definitive Safety Study Is Long Overdue
Off-label Use Of Natrecor Continues To Be A Problem A year ago two medical journal articles raised serious safety issues about Natrecor; in summary: (1) a 50% increased risk of kidney damage or renal…